HIF prolyl-hydroxylase inhibitor
Encyclopedia
HIF prolyl-hydroxylase inhibitors are members of a class of new drugs that act on the hypoxia-inducible factor (HIF) pathway. They are being investigated for treatment of anemia
, chronic kidney disease, cancer, and for their effects on heart tissue and others.
Anemia
Anemia is a decrease in number of red blood cells or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin...
, chronic kidney disease, cancer, and for their effects on heart tissue and others.
See also
- Hypoxia-inducible factors#As a therapeutic target